Symptomtext
The patient was administered an expired Menactra vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via Global Medical Information (GMI) (Reference number- 00555170) and transmitted to Sanofi on 09-Apr-2021. This case involves a patient (demographics unknown) who was administered an expired dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot U6565AA, expiry date: 28-Mar-2021) via unknown route in unknown administration site for prophylactic vaccination on an unknown date (Expired product administered) Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. It was a case of an actual medication error due to expired vaccine used (latency same day) At the time of report, no adverse event was reported The reporter had an incident where a patient was given an expired Menactra vaccine in one of the clinics. They were looking for documentation on whether or not the patient needs to be revaccinated.. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error